Doctor Silverman is a distinguished figure in the field of Maternal-Fetal Medicine, renowned for his extensive research and contributions to obstetric and gynecological care. His work, reflected in a substantial body of published articles, demonstrates a deep commitment to advancing knowledge and improving patient outcomes in complex areas of pregnancy and perinatal health. This compilation of selected references highlights the breadth and depth of Doctor Silverman’s expertise across a range of critical topics within the specialty.
His research encompasses diverse and pressing issues in modern obstetrics. For instance, Doctor Silverman has investigated innovative diagnostic techniques, such as the intra-amniotic instillation of indocyanine green for uncertain cases of preterm rupture of membranes, as detailed in the American Journal of Obstetrics and Gynecology MFM. This study (VanHise K, Dellapiana G, Silverman NS. 2022) showcases his dedication to refining methods for managing challenging obstetric dilemmas and improving diagnostic accuracy in situations where timely intervention is crucial for both mother and child.
Doctor Silverman’s scholarly work also addresses the complexities of genetic evaluations during pregnancy, particularly concerning Congenital Anomalies of the Kidneys and Urinary Tract (CAKUT). In a case report published in Case Reports in Perinatal Medicine (Gong P, Wallerstein R, Silverman NS, Pelletier M, Fissell K. 2022), he and his colleagues explored the difficulties and nuances of genetic assessment in this context. This publication underscores his engagement with cutting-edge issues in prenatal diagnostics and his commitment to navigating the intricate landscape of genetic counseling and testing in obstetrics.
The impact of global health crises on perinatal care is another significant focus of Doctor Silverman’s research. Recognizing the urgent need for clinical guidance during the coronavirus disease 2019 (COVID-19) pandemic, he contributed to the Journal of Perinatal Medicine with an article providing essential clinical recommendations (Afshar Y, Silverman NS, Han CS, Platt LD. 2020). This publication highlights his responsiveness to emerging health threats and his proactive approach to disseminating crucial information to healthcare providers to ensure optimal perinatal care during unprecedented times.
Furthermore, Doctor Silverman has made important contributions to the understanding and management of rare but serious conditions in pregnancy, such as May-Thurner syndrome. His multi-institutional case series and literature review, published in the American Journal of Obstetrics and Gynecology MFM (Mei JY, Deshmukh U, Negi M, Campbell K, Paidas MJ, Platt LD, Silverman NS, Han CS. 2020), enhances the medical community’s knowledge of this condition and provides valuable insights for clinicians managing pregnant patients with this vascular anomaly.
Addressing common clinical challenges, Doctor Silverman has also focused on optimizing diagnostic and management protocols for prevalent issues like penicillin allergy in pregnancy. His article in Obstetrics & Gynecology‘s Clinical Expert Series (Turrentine MA, King T, Silverman NS. 2020) advocates for moving beyond presumptive diagnoses of penicillin allergy towards accurate diagnostic approaches. This work emphasizes his commitment to evidence-based practice and improving the precision of medical interventions in obstetrics.
His expertise extends to the prevention of neonatal early-onset group B streptococcal disease, a critical area of perinatal infectious disease management. Doctor Silverman contributed to the American College of Obstetricians and Gynecologists (ACOG) Committee Opinion No. 797 on this topic (King T, Silverman NS, Turrentine M, ACOG Committee on Obstetric Practice. 2020), demonstrating his leadership in shaping national guidelines and best practices for preventing this serious neonatal infection.
Doctor Silverman’s insights on public health policy and screening recommendations are also evident in his editorial published in JAMA concerning hepatitis B virus screening in pregnant women (Silverman NS. 2019). His commentary on the new USPSTF recommendations reflects his engagement with broader public health issues and his ability to critically analyze and interpret evolving guidelines to inform clinical practice and improve maternal and infant health outcomes.
The challenges posed by emerging infectious diseases, such as the Zika virus, have also been a focus of Doctor Silverman’s research. His publication in Obstetrics & Gynecology (Rao RR, Gaw SL, Han CS, Platt LD, Silverman NS. 2017) explored the clinical practice implications of Zika risk and pregnancy as the outbreak unfolded. This timely research provided crucial guidance for clinicians navigating the uncertainties and complexities of managing Zika virus exposure during pregnancy.
Doctor Silverman’s contributions extend to the management of hematological conditions in pregnancy. He co-authored guidelines on the management of hereditary antithrombin deficiency in pregnancy, published in Thrombosis Research (James AH, Bates SM, Bauer KA, Branch W, Mann K, Paidas M, Silverman N, Konkle BA. 2017). This work highlights his expertise in managing complex medical comorbidities during pregnancy and his commitment to developing evidence-based approaches for optimizing maternal and fetal well-being in these situations.
Finally, Doctor Silverman engages with the ethical dimensions of obstetric care in the context of global health crises. His article in the American Journal of Bioethics (Harris LH, Silverman NS, Marshall MF. 2016) addresses the ethical paradoxes and unequal burdens faced by women, particularly pregnant women, during the Zika epidemic. This publication showcases his thoughtful consideration of the broader societal and ethical implications of medical practice and public health responses in obstetrics.
In conclusion, Doctor Silverman’s body of work exemplifies a career dedicated to advancing Maternal-Fetal Medicine through rigorous research, clinical expertise, and a commitment to addressing the most pressing challenges in obstetric care. His publications serve as valuable resources for the medical community and underscore his position as a leading expert in the field.
Selected references
1. VanHise K, Dellapiana G, Silverman NS. Intra-amniotic instillation of indocyanine green in uncertain cases of preterm rupture of membranes. Amer J Obstet Gynecol MFM 2022 Apr 7:100638.
2. Gong P, Wallerstein R, Silverman NS, Pelletier M, Fissell K. Challenges in genetic evaluation for Congenital Anomalies of the Kidneys and Urinary Tract (CAKUT) spectrum in pregnancy. Case Reports Perinatal Med 2022; 11(1): 20210063.
3. Afshar Y, Silverman NS, Han CS, Platt LD. Clinical guidance and perinatal care in the era of coronavirus disease 2019 (CoVID-19). J Perinatal Med 2020; 48: 925-30.
4. Mei JY, Deshmukh U, Negi M, Campbell K, Paidas MJ, Platt LD, Silverman NS, Han CS. May-Thurner syndrome in pregnancy: A multi-institutional case series and review of the literature. Amer J Obstet Gynecol MFM 2020 Oct 3:100240.
5. Turrentine MA, King T, Silverman NS. Penicillin allergy in pregnancy: Moving from “rash” decisions to accurate diagnosis. Clinical Expert Series. Obstet Gynecol 2020;135: 401-8.
6. King T, Silverman NS, Turrentine M, ACOG Committee on Obstetric Practice. Prevention of neonatal early-onset group B streptococcal disease. ACOG Committee Opinion No. 797. American College of Obstetricians and Gynecologists. Obstet Gynecol 2020;135: e51-72.
7. Silverman NS. Hepatitis B virus screening in pregnant women: the new USPSTF recommendations (editorial). JAMA 2019: 322: 312-14.
8. Rao RR, Gaw SL, Han CS, Platt LD, Silverman NS. Zika risk and pregnancy in clinical practice: Ongoing experience as the outbreak evolves. Obstet Gynecol 2017;129:1098-103.
9. James AH, Bates SM, Bauer KA, Branch W, Mann K, Paidas M, Silverman N, Konkle BA. Management of hereditary antithrombin deficiency in pregnancy. Thrombosis Research 2017; 157: 41-5.
10. Harris LH, Silverman NS, Marshall MF. The paradigm of the paradox: Women, pregnant women, and the unequal burdens of the Zika epidemic. Am J Bioethics 2016; 16: 5, 1-4.
